Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
- PMID: 8610103
- PMCID: PMC39693
- DOI: 10.1073/pnas.93.7.2696
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
Abstract
There is growing evidence that oxidative stress and mitochondrial respiratory failure with attendant decrease in energy output are implicated in nigral neuronal death in Parkinson disease (PD). It is not known, however, which cellular elements (neurons or glial cells) are major targets of oxygen-mediated damage. 4-Hydroxy-2-nonenal (HNE) was shown earlier to react with proteins to form stable adducts that can be used as markers of oxidative stress-induced cellular damage. We report here results of immunochemical studies using polyclonal antibodies directed against HNE-protein conjugates to label the site of oxidative damage in control subjects (ages 18-99 years) and seven patients that died of PD (ages 57-78 years). All the nigral melanized neurons in one of the midbrain sections were counted and classified into three groups according to the intensity of immunostaining for HNE-modified proteins--i.e., no staining, weak staining, and intensely positive staining. On average, 58% of nigral neurons were positively stained for HNE-modified proteins in PD; in contrast only 9% of nigral neurons were positive in the control subjects; the difference was statistically significant (Mann-Whitney U test; P < 0.01). In contrast to the substantia nigra, the oculomotor neurons in the same midbrain sections showed no or only weak staining for HNE-modified proteins in both PD and control subjects; young control subjects did not show any immunostaining; however, aged control subjects showed weak staining in the oculomotor nucleus, suggesting age-related accumulation of HNE-modified proteins in the neuron. Our results indicate the presence of oxidative stress within nigral neurons in PD, and this oxidative stress may contribute to nigral cell death.
Similar articles
-
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?Neurology. 1996 May;46(5):1262-9. doi: 10.1212/wnl.46.5.1262. Neurology. 1996. PMID: 8628464
-
Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases.Alcohol Clin Exp Res. 1998 May;22(S3 Pt 1):145S-149S. doi: 10.1111/acer.1998.22.s3_part1.145s. Alcohol Clin Exp Res. 1998. PMID: 9622393
-
Toxic effects of dopamine metabolism in Parkinson's disease.Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S35-8. doi: 10.1016/S1353-8020(09)70010-0. Parkinsonism Relat Disord. 2009. PMID: 19131041 Review.
-
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.J Neural Transm (Vienna). 1997;104(6-7):661-77. doi: 10.1007/BF01291884. J Neural Transm (Vienna). 1997. PMID: 9444566
-
Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.Free Radic Biol Med. 2017 Oct;111:253-261. doi: 10.1016/j.freeradbiomed.2016.10.490. Epub 2016 Oct 24. Free Radic Biol Med. 2017. PMID: 27789292 Review.
Cited by
-
Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1.Brain Res. 2016 Jul 15;1643:10-7. doi: 10.1016/j.brainres.2016.04.071. Epub 2016 Apr 30. Brain Res. 2016. PMID: 27138068 Free PMC article.
-
Naturally occurring genetic variability in expression of Gsta4 is associated with differential survival of axotomized rat motoneurons.Neuromolecular Med. 2012 Mar;14(1):15-29. doi: 10.1007/s12017-011-8164-8. Epub 2011 Dec 8. Neuromolecular Med. 2012. PMID: 22160604
-
The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer.Front Pharmacol. 2020 Sep 3;11:1297. doi: 10.3389/fphar.2020.01297. eCollection 2020. Front Pharmacol. 2020. PMID: 33013366 Free PMC article. Review.
-
Replication bypass of the trans-4-Hydroxynonenal-derived (6S,8R,11S)-1,N(2)-deoxyguanosine DNA adduct by the sulfolobus solfataricus DNA polymerase IV.Chem Res Toxicol. 2012 Feb 20;25(2):422-35. doi: 10.1021/tx200460j. Epub 2012 Feb 7. Chem Res Toxicol. 2012. PMID: 22313351 Free PMC article.
-
Morphologic assessment of oxidative damage: A review.J Am Aging Assoc. 2000 Jan;23(1):17-24. doi: 10.1007/s11357-000-0003-z. J Am Aging Assoc. 2000. PMID: 23604795 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical